Related by context. All words. (Click for frequent words.) 69 CIMZIA ™ 69 clinically meaningful improvements 69 glycated hemoglobin levels 68 CTAP# Capsules 68 oxycodone CR 68 morphometric vertebral fractures 68 atherogenic dyslipidemia 68 overt nephropathy 67 Hypotension 67 hypoglycemic events 67 salmeterol fluticasone 67 serum urate levels 67 tipranavir r 67 glycosylated hemoglobin HbA1c 67 extrapyramidal symptoms 67 severe exacerbations 67 nicardipine 67 postoperative AF 67 tapentadol ER 67 bronchial hyperresponsiveness 67 clinically meaningful improvement 67 Primary endpoints 67 MCyR 67 serum urate 67 DAS# CRP 67 Tasigna prolongs 66 hyperalgesia 66 NIASPAN 66 PASI scores 66 mucosal inflammation 66 NNT = 66 QTc prolongation 66 intravascular hemolysis 66 Kinoid 66 hyperphenylalaninemia HPA due 66 bezafibrate 66 headache nasopharyngitis 66 intracerebral haemorrhage 66 primidone 66 hemorrhagic complications 66 teriflunomide 66 aminotransferases 66 H2RAs 66 dose atorvastatin 66 AGILECT R 66 serum cortisol 66 serum phosphorous 66 cytopenias 66 tumor necrosis 66 apo B 66 thromboembolic 66 constipation nausea 66 euthymic patients 66 tolterodine ER 66 vitreous floaters 65 PLX STROKE targeting 65 elevated uric acid 65 somatostatin analog 65 left ventricular diastolic 65 cerebrovascular events 65 fluticasone salmeterol 65 serum phosphate 65 EDEMA3 trial 65 glycated hemoglobin HbA1c 65 lispro 65 serum triglyceride levels 65 systemic corticosteroid 65 serum phosphate levels 65 rhinorrhea 65 haematologic 65 CP CPPS 65 artery stenosis 65 zonisamide SR 65 stratifying patients 65 SGPT 65 subjective sleepiness 65 induce orthostatic hypotension 65 pulmonary capillary wedge 65 LV dysfunction 65 Febrile neutropenia 65 elevated IOP 65 hypercholesterolaemia 65 coadministration 65 ATACAND 65 lipid lowering agents 65 recurrent venous thromboembolism 65 colorectal adenoma 65 Pharmacokinetic studies 65 hemoglobin A1c HbA1c 65 hematological toxicity 65 delayed gastric emptying 65 intact parathyroid hormone 65 relapsed MM 65 symptomatic VTE 65 coronary stenosis 64 primary aldosteronism 64 MIRAPEX ER 64 certolizumab 64 tranylcypromine 64 radiotherapy RT 64 AST ALT 64 insulin detemir 64 moderate renal impairment 64 albumin excretion rate 64 postsurgical pain 64 macrovascular events 64 recurrent DVT 64 hemoglobin A1c levels 64 HER2 overexpression 64 Erythropoietic therapies may 64 constipation predominant IBS 64 torsade de pointes 64 thromboembolic complications 64 Apidra ® 64 iPTH 64 riociguat 64 HBeAg seroconversion 64 symptomatic intracranial 64 intracranial hemorrhage ICH 64 Intravenous immunoglobulin 64 cardiovascular calcification 64 BENICAR 64 nadolol 64 TMP SMX 64 rheumatoid arthritis osteoarthritis ankylosing 64 ADCS CGIC 64 SGOT 64 ventricular tachyarrhythmia 64 idiopathic Parkinson disease 64 NSAID associated 64 basal bolus regimen 64 myocardial reperfusion 64 interferon beta therapy 64 pyridostigmine 64 IOP lowering 64 urate lowering 64 systemic hypotension 64 pentoxifylline 64 maximal doses 64 alanine aminotransferase ALT 64 dyslipidaemia 64 triglyceride TG 64 paricalcitol 64 hypophosphatemia 64 cobiprostone 64 recurrent atrial fibrillation 64 transaminase elevations 64 hematologic toxicity 64 contrast induced nephropathy 64 proliferative diabetic retinopathy 64 tapentadol IR 64 aspartate aminotransferase AST 64 inhaled iloprost 64 APTIVUS r 64 aspartate aminotransferase 64 neutropenia dehydration dyspnea 64 receiving XGEVA 64 antiemetics 64 hyperglycaemia 64 MoxDuo TM IR 64 lymphopenia 64 PRADAXA #mg 64 hepatocellular 64 serum PTH 64 fractional shortening 64 antiangiogenic therapy 64 FFNS 64 prolonged QT interval 64 dopaminergic therapy 64 nonhematologic adverse reactions 64 elevated serum creatinine 64 rosuvastatin #mg 64 β blockers 64 neovascular 64 prespecified secondary 64 nausea constipation 64 nocturnal hypoglycaemia 64 fructosamine 64 leucopenia 63 variant angina 63 mcg BID 63 ischemic cardiovascular 63 myeloperoxidase 63 variceal bleeding 63 Cleviprex TM clevidipine 63 plasma creatinine 63 elevated triglyceride levels 63 receiving VELCADE 63 inotropic 63 transaminases 63 irbesartan 63 PCWP 63 Pharmacokinetic parameters 63 neutropenia thrombocytopenia 63 Durezol 63 coronary stenoses 63 CIMZIA TM certolizumab pegol 63 vasomotor 63 refractory gout 63 Thal Dex 63 obstructive CAD 63 virologic breakthrough 63 liver histology 63 parkinsonian symptoms 63 corticosteroid dose 63 tissue oxygenation 63 platelet reactivity 63 salmeterol HFA MDI 63 nasal symptom 63 retinal vein occlusion 63 syncope fainting 63 metformin sulfonylurea 63 #mg doses [002] 63 ALT elevations 63 glomerular filtration 63 NATRECOR ® 63 antiarrhythmic drug 63 RLY# 63 platelet inhibition 63 clevidipine 63 plasma renin activity 63 Fluid retention 63 #.#/#.# mmHg [001] 63 elevated creatinine 63 apolipoprotein B 63 HbA 1C 63 nasopharyngitis headache 63 fasting triglycerides 63 serum aminotransferase levels 63 lipid parameters 63 NPH insulin 63 aldosterone antagonist 63 serum phosphorus 63 achieved statistical significance 63 hypercalcemia 63 acute mania 63 Toxicities 63 1mg dose 63 headache abdominal pain 63 octreotide LAR 63 oral antidiabetic medication 63 clomipramine 63 TEAEs 63 tolerability profiles 63 elevated ALT 63 thromboembolic events 63 cardiovascular morbidity 63 eosinophil count 63 anemia hemoglobin 63 #OHD levels 63 oxcarbazepine 63 uric acid lowering 63 β blocker 63 delayed CINV 63 8mg/kg 63 ACTEMRA TM 63 analgesic efficacy 63 thetreatment 63 ADAS Cog 63 serum potassium 63 pulmonary exacerbations 63 tardive dyskinesia TD 63 conjunctival hyperemia 63 bardoxolone methyl 63 Lipitor #mg 63 arterial thromboembolic events 63 lactate dehydrogenase LDH 63 aspirin clopidogrel 63 #.#mg/dL 63 lenalidomide dexamethasone 63 RAPAFLO R 63 intima media thickness 63 prednisone prednisolone 63 probiotic supplementation 63 hypercalciuria 63 angiographic outcomes 63 intracranial atherosclerosis 63 PAOD 63 L PPDS 63 baseline serum creatinine 63 FUSILEV enhances 62 sweat chloride 62 bone marrow suppression 62 pharmacokinetic equivalence 62 FOLFOX6 62 tamoxifen Nolvadex ® 62 VAPRISOL 62 hepatic fibrosis 62 MADRS score 62 hour bronchodilation 62 ruboxistaurin 62 alanine aminotransferase 62 incontinence episodes 62 refractory ischemia 62 rotigotine 62 prazosin 62 Angiotensin converting enzyme 62 somnolence dizziness 62 airway hyperresponsiveness 62 antiarrhythmic 62 airway hyper responsiveness 62 recurrent VTE 62 embolic stroke 62 Clinically significant 62 solifenacin 62 ritonavir boosted 62 anemia neutropenia 62 somnolence fatigue 62 fluvastatin 62 comorbid depression 62 achieved ACR# 62 TMC# r 62 cerebral ischemia 62 PREZISTA r arm 62 severe hypoglycaemia 62 nausea vomiting headache 62 statistically significant efficacy 62 lopinavir r arm 62 post thrombotic syndrome 62 methotrexate monotherapy 62 Infusion Reactions Severe 62 4mg/kg 62 vasomotor symptoms 62 orthostatic hypotension 62 nondiabetic patients 62 PRADAXA 62 silent ischemia 62 cardiac dysfunction 62 complete cytogenetic response 62 angiotensin II receptor blockers 62 SRBD 62 oral diclofenac 62 vasodilatation 62 myopathy rhabdomyolysis 62 endothelin receptor antagonists 62 dose Iluvien 62 tirofiban 62 unresectable HCC 62 lomitapide 62 CINQUIL 62 peripheral arterial occlusive disease 62 HeFH 62 Hb A1C 62 leukotriene receptor antagonists 62 genotypic resistance 62 Ophena TM 62 ALA PDT 62 ropivacaine 62 phonophobia 62 omeprazole Prilosec 62 neurologic progression 62 hyperprolactinemia 62 Hematologic toxicity 62 secondary efficacy endpoint 62 hemodynamic variables 62 ER CHOP 62 CrCl 62 carbidopa levodopa 62 OGTT 62 microvascular complications 62 urine albumin 62 edifoligide 62 Crohn Disease Activity 62 glycemia 62 electrolyte abnormalities 62 oral antidiabetes 62 abacavir lamivudine 62 cough dyspnea 62 glycosylated hemoglobin levels 62 flecainide 62 dyspareunia 62 urinary N telopeptide 62 ARCALYST ® 62 gross hematuria 62 periprocedural 62 serum triglycerides 62 hematological parameters 62 idraparinux 62 nonpharmacologic 62 NNRTI resistance 62 chronic thromboembolic pulmonary 62 nonfatal MI 62 adjunctive placebo 62 pathologic fractures 62 hyperammonemia 62 postoperative morbidity 62 neutrophil counts 62 angina chest 62 subclinical atherosclerosis 62 #mg dose [002] 62 mmol l 62 serum parathyroid hormone 62 Valdoxan 62 tolvaptan 62 oral levofloxacin 62 ximelagatran 62 desvenlafaxine succinate 62 unresectable tumors 62 RezularTM 62 tumor lysis syndrome 62 oral antidiabetic drugs 62 UPDRS motor 62 hyperkalemia 62 eplerenone 62 conventional DMARDs 62 mild renal insufficiency 62 cerebral perfusion 62 cerebral vasospasm 62 secondary hyperparathyroidism 62 vidofludimus 62 Navelbine 62 nonfatal myocardial infarction MI 62 CIMZIA TM 62 esophagogastric 62 statistically significant reduction 62 nephrotoxicity 62 INCB# [003] 62 mixed hyperlipidemia 62 sulphonylureas 62 abnormal lipid 62 mcg QD 62 interleukin IL -# 62 UPDRS scores 62 EUFLEXXA R 62 brand ciclesonide HFA 62 symptomatic NOH 62 insomnia somnolence 62 KAPIDEX 62 opioid naïve 62 AZILECT 62 diastolic blood pressures 62 LDL HDL 62 ischaemia 62 hsCRP levels 62 velafermin 62 limiting toxicity DLT 62 myoclonus 62 plus methotrexate 62 intravenous cyclophosphamide 62 hepatotoxicity 62 triiodothyronine 62 postoperative complication 62 DDP# 62 Diabetic peripheral neuropathy 62 plasma lipids 61 bisoprolol 61 OAB symptoms 61 pharmacodynamic PD 61 BPH benign prostatic 61 Diabetic neuropathy 61 pioglitazone HCl 61 IV bisphosphonates 61 Cimzia TM 61 intracranial bleeding 61 hypoglycemic episodes 61 paraprotein 61 anaphylactic reactions bronchospasm 61 HOMA IR 61 Nesiritide 61 thiazide diuretic 61 oral rivaroxaban 61 myocardial ischemia 61 Xanafide 61 #mm Hg 61 rhinoconjunctivitis 61 adriamycin 61 HbA 1c 61 Lantus ® 61 daytime drowsiness 61 dosage regimens 61 corticosteroid therapy 61 guanfacine 61 isoproterenol 61 HbA1C levels 61 HRQL 61 glycemic variability 61 fasting hyperglycemia 61 hemodilution 61 statin monotherapy 61 T2DM 61 lumbar disk herniation 61 AZT zidovudine Retrovir 61 improves glycemic 61 thrombotic complications 61 ispinesib administered 61 fasting plasma glucose 61 SSc 61 exploratory endpoints 61 venlafaxine XR 61 hypocalcemia 61 transaminase 61 TNF antagonist 61 Visual Analogue Scale VAS 61 Mg Uk 61 trandolapril 61 abdominal adiposity 61 limiting toxicity 61 pulmonary arterial 61 neutropaenia 61 multivariate adjustment 61 fasting plasma glucose FPG 61 frequent awakenings 61 daytime alertness 61 NR2B selective 61 Adenoscan 61 pramlintide metreleptin combination 61 renal toxicity 61 vitreous haze 61 macroalbuminuria 61 alpha interferons 61 postprandial glycemia 61 subsyndromal 61 maximal tolerated 61 FASLODEX 61 metabolic acidosis 61 upper gastrointestinal bleeding 61 H2 receptor antagonists 61 rimonabant #mg 61 erosive gastritis 61 coagulopathy 61 6R BH4 61 atrial tachyarrhythmias 61 venous hypertension 61 nausea photophobia 61 airflow limitation 61 ULORIC 61 aMCI precursor 61 ibandronate 61 glycosylated hemoglobin 61 NSAID induced 61 favorable tolerability 61 hypocalcaemia 61 variceal hemorrhage 61 AGILECT ® 61 favorable pharmacokinetic profile 61 anticholinergic agents 61 included exfoliative dermatitis 61 plasma triglycerides 61 GERD symptom 61 reinfarction 61 sustained virological response 61 neurocognitive deficits 61 autonomic dysfunction 61 TNF Tumor Necrosis Factor 61 nonalcoholic steatohepatitis NASH 61 carotid artery blockage 61 extrapyramidal symptoms EPS 61 CANCIDAS 61 LDL cholesterol lowering 61 schizophrenia CIAS 61 intravesical therapy 61 prednisone prednisolone plus 61 LANTUS ® 61 poststroke depression 61 prostate cancer PCa 61 postoperative atrial fibrillation 61 gastro esophageal reflux 61 Carotid endarterectomy 61 metastatic neuroendocrine tumors 61 CaPre TM 61 paroxetine sertraline 61 micafungin 61 symptomatic intracranial hemorrhage 61 sJIA 61 microvessel density 61 HIV HCV coinfected 61 angiotensin converting enzyme inhibitor 61 carotid IMT 61 fasting plasma 61 plus prednisone prednisolone 61 Primary Hypercholesterolemia 61 Endothelial dysfunction 61 hypoperfusion 61 prothrombotic 61 Secondary endpoints include 61 CCyR 61 triglycerides TG 61 dizziness nausea diarrhea 61 cardiac repolarization 61 candesartan cilexetil 61 natriuresis 61 hypoglycaemic episodes 61 proliferative retinopathy 61 thrombocytosis 61 angiographically 61 EXJADE 61 overactive bladder symptoms 61 oxygen desaturation 61 levodopa carbidopa 61 evaluating tivozanib 61 VaD 61 Scale EDSS 61 ertapenem 61 haematological toxicity 61 antibiotic rifaximin 61 bleeding pallor 61 urinary albumin 61 olmesartan 61 tumor regressions 61 inflammatory biomarkers 61 Orthokine 61 OSAHS 61 mg BID dose 61 haemodynamic 61 metaglidasen 61 plasma kallikrein inhibitor 61 lipid abnormalities 61 PSA nadir 61 dysuria 61 Non inferiority 61 Severe hypoglycemia 61 ADAGIO study 61 INVEGA ® 61 Secondary endpoints included 61 Oral mucositis 61 metabolic alkalosis 61 binary restenosis 61 Natalizumab 61 abnormal glucose metabolism 61 ezetimibe simvastatin 61 plasma homocysteine 61 gastroduodenal 61 MTP inhibitor 61 dopamine antagonists 61 alanine transaminase 61 Oral corticosteroids 61 gastro oesophageal reflux 61 NMDA antagonist 61 smoldering multiple myeloma 61 Diovan HCT 61 aldosterone hormone 61 LV ejection fraction 61 oxaliplatin Eloxatin 61 simvastatin ezetimibe 61 lumbar spine BMD 61 carotid bruit 61 beta blocker atenolol 61 esomeprazole Nexium 61 diabetic kidney 61 sUA 61 familial hypercholesterolemia FH 61 parasitemia 61 xanthine oxidase inhibitor 61 KRAS mutations occur 61 COPD exacerbation 61 PROCRIT ® 61 ventricular arrhythmia 61 opioid naive 61 INTEGRILIN R 61 intravenous bisphosphonates 61 macrovascular disease 61 ARB telmisartan 61 pharmacodynamics PD 61 AA Amyloidosis 61 dose proportionality 61 headache nausea dizziness 61 aplindore 61 pharmacodynamic effects 61 sargramostim 61 stable angina 61 steroid dexamethasone 61 OADs 61 overt hypothyroidism 61 diarrhea dyspepsia 61 salmeterol inhalation powder 61 diarrhea flatulence 61 asthma exacerbation 61 response CCyR 61 cinacalcet 61 ACEIs 61 non menstrual pelvic 61 cough wheezing 61 COPD exacerbations 61 Secondary endpoints 61 rebleeding 61 hepatic liver 61 ICD shocks 61 ZOMIG 61 FluCAM arm 61 nonischemic 61 choroidal neovascularization CNV 61 cardioembolic stroke 61 PRT# 60 Zorbtive TM 60 p = NS 60 tamsulosin 60 bronchodilation 60 oral prodrug 60 recurrent ischemia 60 ID TLR 60 Combination therapy 60 PR interval prolongation 60 lumbar spine bone 60 biochemical abnormalities 60 benazepril 60 hemodynamic parameters 60 calcium antagonists 60 Navelbine ® 60 EDARBI 60 convulsive disorders 60 serum homocysteine 60 acetabular dysplasia 60 triglyceride concentrations 60 baseline HbA1c 60 serum lipid 60 orally inhaled 60 Insulin detemir 60 hypovolemia 60 progressive dyspnea 60 either acutely decompensated 60 CC genotype 60 CTEPH 60 exhaled NO 60 alicaforsen enema 60 BENICAR HCT 60 macrolide antibiotic 60 lowering blood glucose 60 neurologic dysfunction 60 hypometabolism 60 decompensated cirrhosis 60 depressive symptomatology 60 bothersome symptom 60 novel VDA molecule 60 CK # plasma concentrations 60 electrical cardioversion 60 neurologic symptoms 60 acarbose 60 prospectively stratified 60 bronchodilatory 60 non valvular atrial 60 erythropoietic 60 HBeAg 60 thromboxane A2 60 diabetes dyslipidemia 60 PULMICORT RESPULES 60 sensory neuropathy 60 depression suicidal ideation 60 baminercept 60 opioid induced 60 pyrexia mucositis sepsis febrile 60 peptide BNP 60 QT interval prolongation 60 adrenal suppression 60 CYT# potent vascular disrupting 60 #mg/day [002] 60 impaired cognition 60 Torsades de Pointes 60 HMG CoA reductase inhibitors 60 serum leptin 60 oral olanzapine 60 thrombocytopenia neutropenia 60 lipid lowering therapies 60 alfuzosin 60 serum calcium 60 Montgomery Åsberg Depression 60 ocular inflammation 60 gastrointestinal perforation 60 caspofungin 60 erythrocyte sedimentation rate 60 elevated LDL cholesterol 60 HBeAg negative 60 ß blockers 60 posaconazole 60 subthreshold depression 60 venous stasis ulcers 60 FXIII 60 mineralocorticoid 60 TNFalpha 60 antiresorptive 60 CK MB 60 aminotransferase ALT 60 neovascular diseases 60 CIPN 60 Candesartan 60 creatine kinase 60 timepoints 60 IV DHE 60 trastuzumab Herceptin ® 60 Elocalcitol 60 zolmitriptan 60 torsades de pointes 60 thrombo embolic 60 platelet activation 60 deep venous thromboses 60 liver decompensation 60 calculated creatinine clearance 60 oral anticoagulation 60 analgesic medications 60 NovoSeven ® 60 #mmHg [001] 60 rufinamide 60 non hematological toxicities 60 inecalcitol 60 generation antisense inhibitor 60 oral Hycamtin 60 REMINYL ® 60 posttransplant 60 rFVIIa 60 serum sodium levels 60 severe hypersensitivity reactions 60 catheter occlusion 60 PSA kinetics 60 HbA 1c levels 60 poststroke 60 recurrent genital herpes 60 Telintra 60 CIMZIA R 60 ischemia induced 60 coagulation abnormalities 60 dosing frequency 60 carotid atherosclerosis 60 maximally tolerated lipid lowering 60 anterior uveitis 60 linear pharmacokinetics 60 HER2 expression 60 gemifloxacin 60 salivary flow 60 R Saizen R 60 hepatotoxic 60 RoACTEMRA 60 glycoprotein IIb IIIa inhibitor 60 MP4OX 60 LymphoStat B belimumab 60 opioid analgesia 60 agomelatine 60 Chronic pancreatitis 60 Symptom severity 60 nocturnal hypoglycemia 60 tegaserod 60 factor Xa inhibitor 60 Mg Usa 60 achieving PASI 60 abnormal lipids 60 interferon ribavirin 60 hematologic parameters 60 nonarteritic anterior ischemic optic 60 serum uric acid sUA 60 adalimumab Humira 60 Hepatotoxicity 60 capillary leakage 60 symptom severity 60 hepatic cirrhosis 60 cerebral oxygenation 60 eosinophilia 60 leukopenia 60 silent myocardial ischemia 60 DLTs 60 levodopa therapy 60 heparin induced thrombocytopenia 60 x ULN 60 TURBT 60 pegylated liposomal doxorubicin 60 lumiliximab 60 epoetin alpha 60 hepatic enzymes 60 mmHg diastolic 60 recurrent glioblastoma multiforme 60 AVAPRO 60 peripheral sensory neuropathy 60 HbA1C 60 mm Hg diastolic 60 Index CDAI score 60 hypoxemia 60 ventricular repolarization 60 Brief Psychiatric 60 D aspartate NMDA receptor 60 mechanically ventilated patients 60 intermittent dosing 60 Exclusion criteria 60 Fibromyalgia Impact Questionnaire 60 hip BMD 60 CR CRu 60 diabetes mellitus DM 60 venous thromboembolic disease 60 potassium sparing diuretics 60 Cystatin C 60 psoriatic arthritis PsA 60 Insulin PH# 60 Lixivaptan 60 rosuvastatin Crestor 60 ularitide 60 myelosuppression 60 Severity MSCS score 60 angina pectoris 60 carotid stenosis 60 perioperatively 60 QIDS SR 60 pericardial effusion 60 hypertension diabetes mellitus 60 lispro alone 60 hyperlipidaemia 60 perioperative morbidity 60 Bezielle 60 Apolipoprotein B 60 myocardial ischaemia 60 intraventricular 60 antiphospholipid syndrome 60 colesevelam HCl 60 lupus renal disease 60 Creatinine 60 Aggrastat ® tirofiban hydrochloride 60 Zollinger Ellison Syndrome 60 thromboembolic disease 60 mania hypomania 60 total cholesterol triglycerides 60 diarrhea nausea vomiting 60 intermittent hemodialysis 60 pharmacokinetic PK profile 60 Bisphosphonate 60 esophageal perforation 60 atrioventricular block 60 pretreatment baseline 60 plasma pharmacokinetics 60 LHRH antagonists 60 postprocedure 60 Tekamlo 60 SPIRIVA R 60 sitaxsentan 60 PsA 60 treprostinil 60 paroxysmal AF 60 maximally tolerated dose 60 postoperative pulmonary 60 metabolic dysfunction 60 pharmacologically active isomer 60 detrusor overactivity 60 diarrhea abdominal 60 selective modulator 60 headache nausea diarrhea 60 folinic acid 60 tHcy 60 acutely decompensated congestive heart 60 acute hepatic 60 K ras mutations 60 hippocampal atrophy 60 proton pump inhibitor PPI 60 virologic response 60 reflux symptoms 60 DFMO 60 affective psychoses 60 IPL# 60 Psoriasis Area 60 protease inhibitor PI 60 inflammatory lesions 60 failure ADHF 60 NATRECOR R 60 ancrod 60 GFT# 60 FOLPI 60 sulfasalazine 60 Darapladib 60 mitochondrial toxicity 60 intermittent hypoxia 60 Pioglitazone 60 biphasic insulin aspart 60 hypomagnesemia 60 Fulvestrant 60 EEG abnormalities 60 myocardial infarction ventricular fibrillation 60 postoperative bleeding 60 prognostic indicators 60 antithrombotics 60 sotalol 60 unfavorable cytogenetics 60 PHPT 60 medically refractory 60 apnea hypopnea 60 antioxidant supplementation 60 nonfatal myocardial infarction 60 INVEGA ™ 60 microbiological eradication 60 alpha blocker 60 TNF alpha antagonist 60 symptomatic paroxysmal AF 60 NLX P# 60 alemtuzumab treated 60 neuropsychiatric symptoms 60 cisplatin gemcitabine 60 atopic asthma 60 PEGINTRON TM 60 STRIDE PD 60 latent celiac disease 60 systolic hypertension 60 nonvertebral fracture 60 nausea vomiting constipation 60 serum testosterone 60 ischemia reperfusion 60 serum concentrations 60 epithelial tumors 60 risperidone Risperdal 60 acromegalic patients 60 MAGE A3 ASCI 60 gastrointestinal toxicities 60 CYT# QbG# 60 RLAI 60 hematopoietic cancers 60 arteriography 60 dopamine D2 60 WOMAC pain